Clinical Trials

40 enrolled

Lung Neoplasms

NCT05907512 2023-06-22

Endostar Plus Toripalimab as Adjuvant Therapy for Resectable Stage III-Oligometastatic Stage IV Cutaneous Melanoma

43 enrolled

Dermatologic

Melanoma

NCT05574998 2022-10-12

FTANLCNDG

100 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05529355 2022-09-07

Effect and Safety of Envafolimab Combined With Endostar/S-1 in Second-line of Advanced Non-small Cell Lung Cancer

45 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05298020 2022-03-28

Envafolimab Combined With Endostar and Chemotherapy for First-line Treatment of Advanced Pancreatic Cancer

20 enrolled

Advanced Pancreatic Cancer

NCT05177237 2022-01-04

Endostar Combined With Corticosteroid for Treatment of Radiation-induced Brain Necrosis in Nasopharyngeal Carcinoma

30 enrolled

Nasopharyngeal Carcinoma

NCT02636231 2021-02-03

Endostar for Locally Recurrent Nasopharyngeal Carcinoma

96 enrolled

Nasopharyngeal Carcinoma, Recurrence

NCT04613284 2020-11-03

RELIEF

Phase 4 Unknown

97 enrolled

Lung Neoplasms

NCT03989830 2020-10-23

SLICER

53 enrolled

Head and Neck Neoplasms

NCT04274270 2020-03-19

SBRTLCES

Phase NA Unknown

60 enrolled

Lung Neoplasms, Radiation Injuries

NCT04303130 2020-03-10

Camrelizumab Combined With Endostar for First-line Treatment in Subjects With Advanced Squamous NSCLC

52 enrolled

Carcinoma, Non-Small-Cell Lung

NCT04121975 2019-10-10

CCRT Combined With Endostar for the Treatment of Locally Advanced Cervical Cancer

82 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT01907529 2019-08-09

TENDENCY

Phase 2/3 Unknown

300 enrolled

Breast

Breast Neoplasms

NCT03932266 2019-04-30

Endostar Combined With Induction Chemotherapy and Concurrent Chemoradiotherapy for Locoregional Nasopharyngeal Carcinoma

73 enrolled

Nasopharyngeal Carcinoma

NCT03907098 2019-04-08

Endostar in Combination With Chemotherapy in HER-2 Negative Advanced Breast Cancer

50 enrolled

Breast

Breast Neoplasms

NCT02902432 2019-01-31

A Trial of Endostar in Patients With Carcinoma of the Head and Neck

24 enrolled

Nasopharyngeal Neoplasms

NCT03706703 2018-10-17

Rh-Endostatin (Endostar®) Continuous Intravenous Infusion

50 enrolled

Lung Neoplasms

NCT03649945 2018-08-28

Endostatin Combined With Chemotherapy for Adjuvant Treatment of Esophageal Cancer

186 enrolled

Esophageal Neoplasms

NCT03614065 2018-08-03

Endostar Combine With Radiotherapy in Brain Metastasis of NSCLC

50 enrolled

Carcinoma, Non-Small-Cell Lung

NCT03588494 2018-07-17

Endostar in Combination With Chemoradiotherapy in Patient With Advanced Non-small Cell Lung Cancer

Phase 2/3 Unknown

318 enrolled

Quality of Life

NCT02590133 2017-12-22

A Phase II Clinical Trial of Chemotherapy With or Without Endostar® Continuous Intravenous Infusion in Refractory NPC

328 enrolled

Nasopharyngeal Carcinoma

NCT03123445 2017-04-21

Endostar First-line Treatment of Advanced NSCLC

150 enrolled

Carcinoma, Non-Small-Cell Lung

NCT03095079 2017-03-29

Rh-endostatin in Combination With Dacarbazine and Cisplatin as the First Line Therapy for Metastatic Melanoma

70 enrolled

Dermatologic

Melanoma

NCT02579564 2016-10-21

Systemic Chemotherapy Combined With Recombinant Human Adenovirus Type 5 and Endostatin Injections for Treatment Malignant Hydrothorax in NSCLC Patients

134 enrolled

Carcinoma, Non-Small-Cell Lung

NCT02907710 2016-09-20

Endostar Combined With Concurrent Chemoradiotherapy for Locoregionally Advanced Nasopharyngeal Carcinoma

300 enrolled

Nasopharyngeal Carcinoma

NCT02615106 2016-06-14

Anti-angiogenetic Therapy With Radiotherapy for Pediatric Neuroblastoma

60 enrolled

CNS

Neuroblastoma

NCT02665702 2016-01-28

Endostar Combined With NVB and DDP Second-line Treatment of Advanced Esophageal Squamous Cell Carcinomas

76 enrolled

Esophageal Squamous Cell Carcinoma

NCT01430013 2015-11-04

Trial of Endostar Combined With CHOPT for T Cell Lymphoma

30 enrolled

Lymphoid

Lymphoma, T-Cell

NCT02375022 2015-03-24

Rh-Endostatin in Combination With Icotinib for Advanced NSCLC With EGFR Mutations

10 enrolled

Lung Neoplasms

NCT02350361 2015-01-29

Endostar Combination With Chemotherapy and EGFR-TKI in Lung Cancer Rechallenging Treatment After Acquired Resistance.

Phase 2/3 Unknown

60 enrolled

Lung Neoplasms

NCT01612286 2014-02-19

Endostar Combination With Chemotherapy for the Metastatic Nasopharyngeal Carcinoma

30 enrolled

Nasopharyngeal Carcinoma

NCT02005120 2013-12-20

Intrapleural Administration of Bevacizumab Versus Endostar for Pleural Effusions in NSCLC

20 enrolled

Carcinoma, Non-Small-Cell Lung

NCT02008422 2013-12-11

Clinical Study of Endostar Injection Concomitant With SOX Protocols to Treat Advanced Gastric Cancer

120 enrolled

Stomach Neoplasms

NCT02001168 2013-12-04

Comparison of Postoperative Adjuvant Chemotherapy With/Without Rh-endostatin on Non-small Cell Lung Cancer in PhaseⅠB

392 enrolled

Carcinoma, Non-Small-Cell Lung

NCT01218594 2012-10-17

DP-EN-RT

50 enrolled 7 charts

Carcinoma, Non-Small-Cell Lung

NCT01310478 2011-03-08

Recombinant Human Endostatin in Combination With mFOLFOX6 in Patients With Metastatic Colorectal Cancer

Phase 1 Unknown

15 enrolled

Colorectal Neoplasms

NCT00657423 2010-09-17

Impact of Endostar Combined With Chemotherapy on the Angiogenesis of Advanced Non-small Cell Lung Cancer (NSCLC)

80 enrolled

Lung Neoplasms

NCT00974324 2010-09-15

PTCL

15 enrolled

Lymphoid

Lymphoma, T-Cell, Lymphoma, T-Cell, Peripheral

NCT01158144 2010-07-08

Concurrent Endostar, Paclitaxel/Carboplatin and Radiotherapy for Locally Advanced Non-small Cell Lung (RT0902)

134 enrolled

Carcinoma, Non-Small-Cell Lung

NCT01028729 2009-12-09

NSCLC

Phase 4 Unknown

120 enrolled

Carcinoma, Non-Small-Cell Lung

NCT00813137 2009-12-08

FOLFOX4 Combined With Endostar in Patients With Advanced Colorectal Cancer

120 enrolled

Colorectal Neoplasms

NCT00853684 2009-09-18

OXCE

44 enrolled